knowledge -WSS

knowledge

author：leisure time 2025-09-27 23:32:04 - browse：4

Illustration of a doctor and patient. The shadow behind the doctor displays 0s and 1s for artificial intelligence. –– health tech coverage from STAT — Molly Ferguson for STAT

The world’s largest technology companies are racing to build generative AI into every corner of health and medicine.

Microsoft has formed an alliance with the electronic health records vendor Epic to wire the technology into dozens of health software products. Google is infusing it into tools used by hospitals to collect and organize data on millions of patients. Not to be outdone, Amazon has unveiled a service to help build clinical note scribes, and is separately working to embed generative AI in drug research and development.

All of this has unfolded faster than federal regulators could blink — or answer questions about how the technology should be tested and evaluated, whether it will help or hurt patients, and how it will impact privacy and the use of personal data.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Medicare Advantage coverage denials need scrutiny, senators say

WSS

Study suggests new cause of Down syndrome: cells linked to aging

Physician assistants need a new name. Here's what it should be

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

ADA: All diabetes patients should be screened for liver condition

Physician assistants need a new name. Here's what it should be

explore

knowledge

explore

In age of alternative facts, a scholarly course on calling out crap

Supreme Court strikes down Biden student loan forgiveness program

Trump demands the U.S. pay no more for drugs than other countries … again

Boston Scientific acquires urology company Axonics for $3.7 billion

Heart attack and stroke risk calculators need revising

Merck to acquire Harpoon Therapeutics for $680 million

The cancer drug shortage isn’t new — and neither are the solutions

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

23andMe had bad news about my health. I wish a person had delivered it

Hospital chaplains balance Covid safety with patients’ spiritual needs

leisure time

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

ADA: All diabetes patients should be screened for liver condition

Physician assistants need a new name. Here's what it should be

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Medicare Advantage overpayments discussion gets experts fired up

Ukrainian soldiers say they owe lives to US

focus

entertainment

knowledge

focus